Company / Current Assets per Share
Decoy Therapeutics Inc. Current Assets per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$8.02
FY2022
5-year range
$0.58 / $8.02
FY2018-FY2022
Trend
+533.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share changed +533% YoY in FY2022, a notable deviation from the 6-year average annual change of +117%.
Based on SEC 10-K filings.
8.02 in FY2022 with a 5-year CAGR of +31.3%.
Improved from $3.50 to $8.02 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +51.5%
- 5-Year CAGR
- +31.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current assets per share increased 533.4% year-over-year.
- Lowest current assets per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $8.02 | +533.4% |
| FY2021 | $1.27 | -63.8% |
| FY2020 | $3.50 | +51.6% |
| FY2019 | $2.31 | +298.5% |
| FY2018 | $0.58 | -71.8% |
| FY2017 | $2.06 | -48.1% |
| FY2016 | $3.97 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026